ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CGTN poll: 88.1% of respondents recognized China’s achievements in epidemic prevention over the past three years

Beijing, China / TimesNewswire / January 27, 2023 – China was highly appraised for its achievements in COVID-19 prevention and control, according to a global poll launched by CGTN Think Tank and the Chinese Institute of Public Opinion of Renmin University of China.

The global survey covered 21 countries, including the United States, Britain, France, Germany and Italy, of which 88.1 percent of respondents recognized China’s achievements in epidemic prevention and control over the past three years, and the figure was 93.4 percent among respondents from Asian, African and Latin American countries.

China has been upholding to the principle of “putting the people and their lives first” and optimizing its epidemic response in its three-year fight against the virus.

The country launched the world’s largest vaccination campaign and managed to protect key populations. So far, there are more than 6.63 million deaths due to COVID-19 globally, and China’s severe cases and death rates are among the lowest.

The survey showed that 71.6 percent respondents recognized China’s dynamic adjustments to its COVID-19 policies.

Regarding China’s preparations to downgrade its infectious disease management from Class A to Class B, 76.2 percent of respondents considered the relevant measures to be positive and effective. These measures include opening as many fever clinics as possible to meet public demand for medical services, increasing the number of ICU beds, and ensuring timely admissions for severe and critically-ill patients.

The figure was even higher among Asian, African and Latin American respondents at 82.5 percent.

China’s average annual economic growth rate over the past three years was 4.5 percent. In 2022, its GDP exceeded 121 trillion yuan (about $17.8 trillion).

86.8 percent of global respondents recognized China’s efforts in coordinating epidemic prevention and control with economic and social development, and the figure was as over 91 percent among respondents from Asian, African and Latin American countries.

Around three quarters of respondents from Western countries also gave a positive view of China’s performance regarding this.

China has provided more than 2.2 billion doses of COVID-19 vaccine to more than 120 countries and international organizations, and provided a large number of protective suits, ventilators, masks and other supplies to 153 countries and 15 international organizations over the past three years.

According to the survey, over 85 percent of respondents spoke highly of China’s contribution to the global defenses against the COVID-19.

In Nigeria and Pakistan, where Chinese vaccines have been donated, 88 percent of respondents believed Chinese vaccines were safe and effective.

Some Western media have been criticizing China’s three-year epidemic prevention policies, whether it imposed strict or relaxed controls.

Of those surveyed who thought the reports were unfair, 77.7 percent said these reports were politically biased, compared with 70 percent in Western countries.

As for some countries imposing COVID-19 restrictions on Chinese travelers, over 70 percent of respondents believed it is wrong to politicize the epidemic, and around 68 percent said such discriminatory measures should be withdrawn immediately.

The survey also showed that 96.6 percent of respondents called on countries to put aside prejudice and join hands to tackle challenges.

Source: https://news.cgtn.com/news/2023-01-26/CGTN-poll-China-s-achievements-in-COVID-19-prevention-recognized-1gTKpAg6W6k/index.html

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.